Page 53 - GTM-3-3
P. 53
Global Translational Medicine Ocular changes in Alzheimer’s disease
67. Frost S, Kanagasingam Y, Sohrabi H, et al. Retinal 76. Den Haan J, van de Kreeke JA, van Berckel BN, et al. Is retinal
vascular biomarkers for early detection and monitoring of vasculature a biomarker in amyloid proven Alzheimer’s
Alzheimer’s disease. Transl Psychiatry. 2013;3(2):e233. disease? Alzheimers Dement (Amst). 2019;11:383-391.
doi: 10.1038/tp.2012.150 doi: 10.1016/j.dadm.2019.03.006
68. Shi H, Koronyo Y, Rentsendorj A, et al. Identification of 77. Ramrattan RS, Van Der Schaft TL, Mooy CM, de Bruijn WC,
early pericyte loss and vascular amyloidosis in Alzheimer’s Mulder PG, de Jong PT. Morphometric analysis of Bruch’s
disease retina. Acta Neuropathol. 2020;139:813-836. membrane, the choriocapillaris, and the choroid in aging.
Invest Ophthalmol Vis Sci. 1994;35(6):2857-2864.
doi: 10.1007/s00401-020-02134-w
78. Ning A, Cui J, To E, Ashe KH, Matsubara J. Amyloid-
69. Sagare AP, Sweeney MD, Makshanoff J, Zlokovic BV. beta deposits lead to retinal degeneration in a mouse
Shedding of soluble platelet-derived growth factor model of Alzheimer disease. Invest Ophthalmol Vis Sci.
receptor-β from human brain pericytes. Neurosci Lett. 2008;49(11):5136-5143.
2015;607:97-101.
doi: 10.1167/iovs.08-1849
doi: 10.1016/j.neulet.2015.09.025
79. Jirarattanasopa P, Ooto S, Nakata I, et al. Choroidal thickness,
70. Dollery CT, Bulpitt CJ, Kohner EM. Oxygen supply to the vascular hyperpermeability, and complement factor H in
retina from the retinal and choroidal circulations at normal age-related macular degeneration and polypoidal choroidal
and increased arterial oxygen tensions. Invest Ophthalmol. vasculopathy. Invest Ophthalmol Vis Sci. 2012;53(7):
1969;8(6):588-594. 3663-3672.
71. Laviers H, Zambarakji H. Enhanced depth imaging-OCT of doi: 10.1167/iovs.12-9619
the choroid: A review of the current literature. Graefes Arch
Clin Exp Ophthalmol. 2014;252(12):1871-1883. 80. Yoonessi A, Yoonessi A. Functional assessment of magno,
parvo and konio-cellular pathways; Current state and
doi: 10.1007/s00417-014-2840-y future clinical applications. J Ophthalmic Vis Res. 2011;6(2):
72. Salobrar-García E, de Hoz R, Ramírez AI, et al. Changes in 119-126.
visual function and retinal structure in the progression of 81. Rizzo M, Anderson SW, Dawson J, Nawrot M. Vision
Alzheimer’s disease. PLoS One. 2019;14(8):e0220535. and cognition in Alzheimer’s disease. Neuropsychologia.
doi: 10.1371/journal.pone.0220535 2000;38(8):1157-1169.
73. Choi W, Mohler KJ, Potsaid B, et al. Choriocapillaris and doi: 10.1016/S0028-3932(00)00023-3
choroidal microvasculature imaging with ultrahigh speed 82. Tippett WJ, Sergio LE. Visuomotor integration is impaired
OCT angiography. PLoS One. 2013;8(12):e81499. in early stage Alzheimer’s disease. Brain Res. 2006;1102(1):
doi: 10.1371/journal.pone.0081499 92-102.
74. Bayhan H, Bayhan S, Celikbilek A, et al. Evaluation of the doi: 10.1016/j.brainres.2006.04.049
chorioretinal thickness changes in Alzheimer’s disease using 83. Polo V, Rodrigo MJ, Garcia-Martin E, et al. Visual dysfunction
spectral‐domain optical coherence tomography. Clin Exp and its correlation with retinal changes in patients with
Ophthalmol. 2015;43(2):145-151. Alzheimer’s disease. Eye (Lond). 2017;31(7):1034-1041.
doi: 10.1111/ceo.12386 doi: 10.1038/eye.2017.23
75. Bulut M, Yaman A, Erol MK, et al. Choroidal thickness in 84. Stein JD, Khawaja AP, Weizer JS. Glaucoma in adults-
patients with mild cognitive impairment and Alzheimer’s screening, diagnosis, and management: A review. JAMA.
type dementia. J Ophthalmol. 2016;2016:7291257. 2021;325(2):164-174.
doi: 10.1155/2016/7291257 doi: 10.1001/jama.2020.21899
Volume 3 Issue 3 (2024) 14 doi: 10.36922/gtm.4094

